StockData

Universe Pharmaceuticals INC (UPC) stock

UPCNasdaqPharmaceutical PreparationsFiscal year ends September 30
Financials through fiscal 2025, year ended Sep 30, 2025Last filing: 20-F on Jan 29, 2026Score 5/30
$1.56+0.08 (+5.41%)

Close on Nov 17, 2026Market cap $878.81KP/E –Yield –

Universe Pharmaceuticals operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

For fiscal 2025 it was -$5.05B. The highest annual figure on record is $1.12B in fiscal 2023.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Sep 30, 2025-$5.05B–
FY2024Sep 30, 2024-$9.51B-951.3%
FY2023Sep 30, 2023$1.12B–
FY2022Sep 30, 2022-$1.30M–
FY2021Sep 30, 2021-$2.06M-133.6%
FY2020Sep 30, 2020$6.12M-53.7%
FY2019Sep 30, 2019$13.20M–

More Universe Pharmaceuticals figures

See a number that looks wrong?